Baseline clinical and biochemical characteristics of the study groups
| Control group | Triple therapy group | Reference material | |
|---|---|---|---|
| n (male/female) | 8 (4/4) | 8 (3/5) | 10 (8/2) |
| Age (years) | 61 ± 2 | 66 ± 4 | 56 ± 3 |
| BMI (kg/m2) | 31.3 ± 1.9 | 32.1 ± 2.1 | 29.0 ± 0.5 |
| HbA1c (%) | 9.1 ± 0.4 | 8.8 ± 0.9 | 5.4 ± 0.1 |
| Fasting blood glucose (mmol/l) | 10.3 ± 1.1 | 9.3 ± 1.3 | 5.3 ± 0.1 |
| Fasting serum insulin (pmol/l) | 104 ± 10 | 104 ± 14 | 30 ± 6 |
| Fasting serum C-peptide (pmol/l) | 585 ± 103 | 715 ± 152 | 509 ± 50 |
| Insulin dose per day (units/kg body wt) | 0.46 ± 0.16 | 0.42 ± 0.16 | 0 |
| Duration of diabetes (years) | 7.3 ± 0.9 | 10.9 ± 2.6 | 0 |
| Years on insulin | 3.3 ± 1.2 | 5.1 ± 2.0 | 0 |
Data are means ± SE.